Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterizing the Effect of Dopamine on Markers of Lymph Re-circulation in Fontan-associated Protein-losing Enteropathy

NCT03322345 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT03322345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03322345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterizing the Effect of Dopamine on Markers of Lymph Re-circulation in Fontan-associated Protein-losing Enteropathy
Lead sponsor
University of Michigan
Phase
Observational
Overall status
Terminated
Start date
April 9, 2019
Completion date
May 14, 2026
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

catecholamine, congenital heart disease, dopamine, lymph, lymphatic system, protein-losing enteropathies, single-ventricle